Epigenomics has released additional results from the comparative study aimed to know non-inferiority of Epi proColon assay performance in comparison to fecal immunochemical testing (FIT). The additional data had shown that Epi proColon ...
Tags: Epigenomics, additional data, Epi proColon, Medicine
UK users download the most data on their mobiles, according to a new report from UK telecoms regulator Ofcom. The International Communications Report for 2011 compared 17 countries around the globe, but found the average 424MB download by ...
Tags: data, mobiles, UK users, mobile data
Insulet, a provider of tubeless insulin pump technology, has reported a net loss of $12.42m, or $0.26 per share, for the third quarter ended 30 September 2012 compared to a net loss of $13.56m, or $0.29 per diluted share, for the third ...
Tags: Insulet, tubeless insulin pump technology, Financial situation
Tony Carrara, FactoryTalk View SE Product Manager, Rockwell Automation Uncover the Hidden Alarm Capabilities in Your System With any new tech device, whether a cell phone or plant-floor controller, there is inevitably a helpful feature ...
CAS DataLoggers recently provided the data acquisition solution for a leading German manufacturer of marine diesel engines and compact turbochargers, enabling optimal levels of performance, fuel consumption, and emissions. The ...
Tags: Diesel Engine, Monitoring Diesel Engine, Turbochargers
Pfizer has won US FDA approval for its rheumatoid arthritis (RA) therapy, Xeljanz (tofacitinib citrate) 5mg twice daily, indicated for patients who failed to respond to methotrexate. Xeljanz can be used as a single treatment regime or as ...
Tags: Pfizer, tofacitinib citrate, Xeljanz
Furiex Pharmaceuticals said Takeda Global Research & Development Center has resubmitted New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for alogliptin and fixed-dose combination therapy alogliptin and pioglitazone ...
Tags: Furiex Pharmaceuticals, NDAs, alogliptin and pioglitazone
Takeda Pharmaceutical has received a complete response letter from the US Food and Drug Administration (FDA) regarding its new drug applications (NDAs) for alogliptin and the fixed-dose combination therapy alogliptin and pioglitazone. ...
Tags: FDA, alogliptin, clinical trial program
Lumenpulse Patents Digital Powerline Controls Lumenpulse Inc.,an innovator and manufacturer of high-performance,architectural LED-based lighting solutions for commercial,institutional,and urban environments,announced that it has received ...
Tags: Lumenpulse, LED, Lumentalk
UK-For the first time,the prestigious Knights of Illumination Awards,hosted by Clay Paky,incorporated special new effects,much to the delight of both guests and organizers.The awards,which were held on Sunday 9 September at Battersea ...
Genzyme, a Sanofi company, has received a refuse to file letter from the US Food and Drug Administration (FDA) in response to the supplemental Biologics License Application (sBLA) for the approval of Lemtrada (alemtuzumab) as a treatment ...
Tags: Genzyme, Lemtrada marketing, FDA
Computerworld - Verizon Wireless Tuesday revealed that there are five additional data tiers over and above the six tiers announced with its Share Everything plans earlier this summer. The new top tier costs $150 a month for 20GB, a ...
Web users voluntarily compromise their privacy by typing more personal information into online forms than is strictly needed, a study has found. Researchers at the University of Cambridge and University College London invited a group of ...
Tags: online forms, personal information, WEIS, privacy
Lumenpulse, a manufacturer of high performance, architectural LED-based lighting solutions for commercial, institutional, and urban environments, recently announced it has received US Patent 8,179,058. The patent, the first of seven pending ...
Tags: Market View, raw material, led driver
Lumenpulse recently declared that it has achieved a U.S.Patent 8,179,058 issued on May 15,2012.This patent tops the other seven pending around Lumenpulse's Lumentalk technology. It fosters a novel method,wherein a traditional analog TRIAC ...
Tags: Lumenpulse, U.S.Patent, Lumentalk Technology